NVCR NovoCure Ltd
Price Chart
Executive Summary
Seven NovoCure directors sold identical blocks of 2,945 shares each at $15.77 on June 2, 2026, totaling $325K in open-market sales. The uniform size and timing strongly suggest a coordinated sale, likely tied to a pre-arranged plan or tax-related event rather than opportunistic bearish conviction. Two directors also received non-cash stock grants on June 3, further supporting a routine compensation/planning context. At $2.1B market cap, the $325K represents just 0.015% of market cap — well below the 0.1% materiality threshold.
Key Financial Metrics
Actionable Insight
The uniform sale pattern across all directors is consistent with a pre-arranged 10b5-1 plan or tax-withholding event tied to vesting, not a coordinated bearish signal. No C-suite participation and the minuscule dollar amount relative to market cap make this a non-event for traders. Monitor for any subsequent Form 4 filings that clarify the plan structure, but no immediate action warranted.
Key Facts
- Seven directors each sold exactly 2,945 shares at $15.7707 on June 2, 2026 — identical size and price point across all sellers
- Total open-market sale value: $325,112.98 (0.015% of $2.1B market cap)
- Two directors (Vernon W. Anthony and Martin J. Madden) received non-cash stock grants totaling 28,609 shares on June 3, 2026
- No C-suite executives (CEO, CFO, COO) participated in the sales — only board members
- Recent 30-day insider activity shows 6 prior sells totaling $279K, suggesting ongoing routine portfolio management
Financial Impact
Total sales of $325K represent 0.015% of market cap — economically trivial
Risk Factors
- If the sales were not pre-arranged, the unanimity could indicate a shared negative view — but the trivial size makes this unlikely to be material
- The stock grants on June 3 could trigger additional selling to cover taxes, but amounts remain small
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NVCR-1780691177500 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
8-K
| $17.17 awaiting T+1 | awaiting T+1 | — | $17.78 (+3.55%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $17.99 $17.16 | ▼ −4.61% | ▼ −2.04% | $17.78 (−1.17%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $17.99 $17.16 | ▼ −4.61% | ▼ −2.02% | $17.78 (−1.17%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $12.23 $13.02 | ▲ +6.46% | ▲ +5.44% | $17.78 (+45.38%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $13.67 $13.52 | ▼ −1.10% | ▼ −1.15% | $17.78 (+30.07%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $13.67 $13.52 | ▲ +1.10% | ▲ +1.15% | $17.78 (−30.07%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $13.67 $13.52 | ▼ −1.10% | ▼ −1.15% | $17.78 (+30.07%) |
|
Feb 26, 2026
15w ago
|
8-K
| $13.75 $13.67 | ▼ −0.58% | ▼ −0.13% | $17.78 (+29.31%) |
|
Feb 24, 2026
15w ago
|
8-K
| $14.99 $13.75 | ▼ −8.27% | ▼ −7.73% | $17.78 (+18.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access